The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells
Mansour Haddad Faculty of Pharmacy, Philadelphia University, Amman, JordanCorrespondence: Mansour Haddad Email Dr.man.haddad@gmail.comBackground: Various factors trigger the inflammatory response and cytokine activation in skeletal muscle. Inflamed muscle will exhibit significant levels of inflammat...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dc562069441f4115b2bde8b1e47df35d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:dc562069441f4115b2bde8b1e47df35d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:dc562069441f4115b2bde8b1e47df35d2021-12-02T15:07:50ZThe Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells1178-7031https://doaj.org/article/dc562069441f4115b2bde8b1e47df35d2021-08-01T00:00:00Zhttps://www.dovepress.com/the-impact-of-cb1-receptor-on-inflammation-in-skeletal-muscle-cells-peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Mansour Haddad Faculty of Pharmacy, Philadelphia University, Amman, JordanCorrespondence: Mansour Haddad Email Dr.man.haddad@gmail.comBackground: Various factors trigger the inflammatory response and cytokine activation in skeletal muscle. Inflamed muscle will exhibit significant levels of inflammation and cytokine activity. Interleukin-6 (IL-6), a pro-inflammatory cytokine, exerts pleiotropic effects on skeletal muscle. Endocannabinoid produced by all cell types binds to a class of G protein-coupled receptors, in particular cannabinoid CB1 receptors, to induce skeletal muscle actions.Objective: The purpose of this research was to discover whether activation of cannabinoid CB1 receptors in L6 skeletal muscle cells may promote IL-6 gene expression.Materials and Methods: L6 skeletal muscle cells were cultured in 25 cm2 flasks and quantitative reverse transcription-polymerase chain reaction (probe-based) utilised to quantify IL-6 gene expression levels among different treatment settings.Results: Arachidonyl-2ʹ-chloroethylamide (ACEA) 10 nM, a persistent selective CB1 receptor agonist, promotes IL-6 gene expression in a time-dependent manner. Rimonabant 100 nM, a selective cannabinoid CB1 receptor antagonist, blocks the impact of ACEA. However, insulin does not change IL-6 gene expression.Conclusion: For the first time, a unique link between ACEA and IL-6 up-regulation has been established; IL-6 up-regulation generated by ACEA is mediated in skeletal muscle through cannabinoid CB1 receptor activation. As a result, cannabinoid CB1 receptors may be useful pharmaceutical targets in the treatment of inflammation and related disorders in skeletal muscle tissues.Keywords: cannabinoid CB1 receptors, skeletal muscle, interleukin 6, ACEA, inflammationHaddad MDove Medical Pressarticlecannabinoid cb1 receptorsskeletal muscleinterleukin 6aceainflammationPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 3959-3967 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cannabinoid cb1 receptors skeletal muscle interleukin 6 acea inflammation Pathology RB1-214 Therapeutics. Pharmacology RM1-950 |
spellingShingle |
cannabinoid cb1 receptors skeletal muscle interleukin 6 acea inflammation Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Haddad M The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells |
description |
Mansour Haddad Faculty of Pharmacy, Philadelphia University, Amman, JordanCorrespondence: Mansour Haddad Email Dr.man.haddad@gmail.comBackground: Various factors trigger the inflammatory response and cytokine activation in skeletal muscle. Inflamed muscle will exhibit significant levels of inflammation and cytokine activity. Interleukin-6 (IL-6), a pro-inflammatory cytokine, exerts pleiotropic effects on skeletal muscle. Endocannabinoid produced by all cell types binds to a class of G protein-coupled receptors, in particular cannabinoid CB1 receptors, to induce skeletal muscle actions.Objective: The purpose of this research was to discover whether activation of cannabinoid CB1 receptors in L6 skeletal muscle cells may promote IL-6 gene expression.Materials and Methods: L6 skeletal muscle cells were cultured in 25 cm2 flasks and quantitative reverse transcription-polymerase chain reaction (probe-based) utilised to quantify IL-6 gene expression levels among different treatment settings.Results: Arachidonyl-2ʹ-chloroethylamide (ACEA) 10 nM, a persistent selective CB1 receptor agonist, promotes IL-6 gene expression in a time-dependent manner. Rimonabant 100 nM, a selective cannabinoid CB1 receptor antagonist, blocks the impact of ACEA. However, insulin does not change IL-6 gene expression.Conclusion: For the first time, a unique link between ACEA and IL-6 up-regulation has been established; IL-6 up-regulation generated by ACEA is mediated in skeletal muscle through cannabinoid CB1 receptor activation. As a result, cannabinoid CB1 receptors may be useful pharmaceutical targets in the treatment of inflammation and related disorders in skeletal muscle tissues.Keywords: cannabinoid CB1 receptors, skeletal muscle, interleukin 6, ACEA, inflammation |
format |
article |
author |
Haddad M |
author_facet |
Haddad M |
author_sort |
Haddad M |
title |
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells |
title_short |
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells |
title_full |
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells |
title_fullStr |
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells |
title_full_unstemmed |
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells |
title_sort |
impact of cb1 receptor on inflammation in skeletal muscle cells |
publisher |
Dove Medical Press |
publishDate |
2021 |
url |
https://doaj.org/article/dc562069441f4115b2bde8b1e47df35d |
work_keys_str_mv |
AT haddadm theimpactofcb1receptoroninflammationinskeletalmusclecells AT haddadm impactofcb1receptoroninflammationinskeletalmusclecells |
_version_ |
1718388420406935552 |